Cem Gabay
#113,355
Most Influential Person Now
Researcher
Cem Gabay's AcademicInfluence.com Rankings
Cem Gabaycomputer-science Degrees
Computer Science
#4355
World Rank
#4585
Historical Rank
Computer Engineering
#28
World Rank
#29
Historical Rank
Computational Linguistics
#400
World Rank
#406
Historical Rank
Machine Learning
#826
World Rank
#837
Historical Rank

Download Badge
Computer Science
Cem Gabay's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Cem Gabay Influential?
(Suggest an Edit or Addition)Cem Gabay's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Acute-phase proteins and other systemic responses to inflammation. (1999) (6193)
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs (2010) (4048)
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update (2010) (2474)
- Interleukin-6 and chronic inflammation (2006) (1218)
- Interleukin-1 receptor antagonist: role in biology. (1998) (1049)
- IL‐1, IL‐18, and IL‐33 families of cytokines (2008) (808)
- IL-1 pathways in inflammation and human diseases (2010) (690)
- Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial (2013) (597)
- The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases. (2015) (358)
- EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis (2012) (349)
- Leptin Signaling Deficiency Impairs Humoral and Cellular Immune Responses and Attenuates Experimental Arthritis1 (2002) (335)
- Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. (1997) (327)
- Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. (2007) (322)
- Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. (2009) (310)
- IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? (2002) (292)
- Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics (2014) (278)
- IL-36R ligands are potent regulators of dendritic and T cells. (2011) (272)
- Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage* (2009) (259)
- CD14 Is an Acute-Phase Protein1 (2004) (249)
- Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. (1997) (246)
- Leptin deficiency enhances sensitivity to endotoxin-induced lethality. (1999) (245)
- Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. (2018) (240)
- Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition. (2017) (240)
- B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents. (2007) (234)
- Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries (2011) (218)
- Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. (2003) (218)
- Interleukin-33 biology with potential insights into human diseases (2011) (211)
- Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. (2005) (208)
- Prevotella copri in individuals at risk for rheumatoid arthritis (2019) (203)
- The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. (2006) (192)
- Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease (2017) (192)
- Regulation and function of interleukin‐36 cytokines in homeostasis and pathological conditions (2015) (191)
- Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis. (2009) (190)
- Distinct expression of interleukin (IL)‐36α, β and γ, their antagonist IL‐36Ra and IL‐38 in psoriasis, rheumatoid arthritis and Crohn's disease (2015) (187)
- IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells. (2012) (186)
- Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis (2005) (181)
- Is IL-1 a good therapeutic target in the treatment of arthritis? (2006) (173)
- The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. (2008) (173)
- Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? (2009) (170)
- Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes. (2001) (167)
- Systemic rheumatoid vasculitis: a review. (2006) (162)
- Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid. (1997) (146)
- The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes (2006) (136)
- Regulation and function of interleukin‐36 cytokines (2018) (135)
- The role of leptin in innate and adaptive immune responses (2006) (127)
- Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study (2004) (126)
- Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study. (2007) (120)
- Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions (2012) (120)
- Rituximab in the treatment of antisynthetase syndrome (2005) (115)
- Physiologic role of interleukin-1 receptor antagonist (2000) (114)
- The Proinflammatory Cytokine Response to Chlamydia trachomatis Elementary Bodies in Human Macrophages Is Partly Mediated by a Lipoprotein, the Macrophage Infectivity Potentiator, through TLR2/TLR1/TLR6 and CD141 (2008) (112)
- Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis (2015) (112)
- Elevated serum levels of free interleukin-18 in adult-onset Still's disease. (2016) (111)
- Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. (2011) (107)
- Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center. (2011) (106)
- Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion. (2002) (103)
- Cigarette smoking and radiographic progression in rheumatoid arthritis (2007) (102)
- Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response. (1994) (101)
- Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement (2012) (101)
- The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study. (2011) (100)
- Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis (2007) (100)
- Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis. (2010) (95)
- IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro (2017) (93)
- Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice. (2018) (88)
- Indirect Effects of Leptin Receptor Deficiency on Lymphocyte Populations and Immune Response in db/db Mice1 (2006) (88)
- Bone mineral density in patients with end-stage renal failure. (1993) (87)
- The effectiveness of anti-tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: a population-based study. (2006) (87)
- Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. (2012) (87)
- Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. (1993) (85)
- Leptin deficiency enhances sensitivity to endotoxin-induced lethality. (1999) (82)
- Elevated Levels of Tumor Necrosis Factor-Alpha in Periradicular Fat Tissue in Patients With Radiculopathy From Herniated Disc (2008) (81)
- Assessment of the efficacy of different statins in murine collagen-induced arthritis. (2004) (79)
- Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1beta on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production. (1999) (76)
- The role of female hormonal factors in the development of rheumatoid arthritis (2016) (75)
- Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration (2011) (75)
- Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study (2015) (75)
- Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure. (2009) (73)
- Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo. (1997) (73)
- Production of IL‐1 receptor antagonist by hepatocytes is regulated as an acute‐phase protein in vivo (2001) (72)
- Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee (2014) (70)
- The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases (2009) (68)
- A role for leptin in rheumatic diseases? (2003) (68)
- Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry. (2015) (68)
- Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice. (2016) (65)
- Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists. (2010) (65)
- Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype (2017) (61)
- The mouse interleukin (Il)33 gene is expressed in a cell type‐ and stimulus‐dependent manner from two alternative promoters (2012) (60)
- Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines. (2016) (60)
- Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial. (2010) (60)
- Cytokines in the rheumatic diseases. (2004) (59)
- Mouse neutrophils express the decoy type 2 interleukin‐1 receptor (IL‐1R2) constitutively and in acute inflammatory conditions (2013) (57)
- Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients (2012) (57)
- Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist. (2010) (57)
- The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study (2008) (57)
- Do synovial leptin levels correlate with pain in end stage arthritis? (2013) (55)
- The effect of alcohol on radiographic progression in rheumatoid arthritis. (2010) (55)
- Myeloid‐Related Proteins 8 and 14 Contribute to Monosodium Urate Monohydrate Crystal–Induced Inflammation in Gout (2014) (55)
- IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome. (2019) (54)
- Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis. (2001) (54)
- Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice (2004) (54)
- Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases – a longitudinal study (2015) (53)
- Interferon β stimulates interleukin 1 receptor antagonist production in human articular chondrocytes and synovial fibroblasts (2003) (53)
- Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis (2020) (53)
- The severity of experimental arthritis is independent of IL-36 receptor signaling (2013) (51)
- Leptin activates the promoter of the interleukin-1 receptor antagonist through p42/44 mitogen-activated protein kinase and a composite nuclear factor kappa B/PU.1 binding site. (2003) (50)
- Nanocrystal-Polymer Particles: Extended Delivery Carriers for Osteoarthritis Treatment. (2018) (49)
- Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis (2017) (47)
- Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial (2011) (47)
- Production of interleukin-1 receptor antagonist by human articular chondrocytes (2002) (47)
- Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism. (2018) (46)
- β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion. (2018) (44)
- Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients. (2010) (43)
- Cardiovascular risk in patients with rheumatoid arthritis (2017) (43)
- Cytokine inhibitors in the treatment of rheumatoid arthritis (2002) (42)
- Evaluation of cardiovascular risk in patients with rheumatoid arthritis: Do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? (2012) (42)
- Lower level of synovial fluid interferon-gamma in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomatis reactive arthritis. (2003) (42)
- Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice (2009) (42)
- Corticosteroid therapy for the treatment of acute attacks of crystal-induced arthritis: an effective alternative to nonsteroidal antiinflammatory drugs. (1996) (42)
- IL‐1 receptor antagonist (IL‐1Ra) does not inhibit the production of C‐reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells (1995) (41)
- Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis (2018) (41)
- Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration (2016) (40)
- Expression and function of junctional adhesion molecule-C in human and experimental arthritis (2007) (40)
- Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial (2020) (40)
- Peptidomimetic Fluoromethylketone Rescues Mice from Lethal Endotoxic Shock (1999) (40)
- Anti-RA 33 antinuclear autoantibody in rheumatoid arthritis and mixed connective tissue disease: comparison with antikeratin and antiperinuclear antibodies. (1993) (39)
- At the horizon of innovative therapy in rheumatology: new biologic agents (2008) (39)
- Inflammation: IL-36 has proinflammatory effects in skin but not in joints (2014) (39)
- Synovial tissues concentrate secreted APRIL (2009) (39)
- Variable domain N‐linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B‐cell selection (2018) (38)
- Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients (2010) (38)
- Prolonged treatment with Tadekinig alfa in adult-onset Still’s disease (2018) (37)
- Treatment of rheumatoid arthritis with IL-1 inhibitors (2004) (37)
- Mice transgenic for intracellular interleukin‐1 receptor antagonist type 1 are protected from collagen‐induced arthritis (2003) (37)
- Remission of collagen‐induced arthritis is associated with high levels of transforming growth factor‐β expression in the joint (2006) (37)
- IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome. (2019) (36)
- Molecular Characterization and Subcellular Localization of Macrophage Infectivity Potentiator, a Chlamydia trachomatis Lipoprotein (2007) (34)
- SIK inhibition in human myeloid cells modulates TLR and IL‐1R signaling and induces an anti‐inflammatory phenotype (2016) (34)
- Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency (2013) (33)
- Limited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection (2015) (33)
- Joint Damage Progression in Patients with Rheumatoid Arthritis in Clinical Remission. Do Biologics Perform Better Than Synthetic Antirheumatic Drugs? (2014) (32)
- Acute Phase Proteins (2001) (32)
- Hand osteoarthritis: new insights. (2013) (32)
- Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study (2015) (32)
- A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease (2016) (31)
- Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis. (1993) (31)
- Discrimination of COVID‐19 From Inflammation‐Induced Cytokine Storm Syndromes Using Disease‐Related Blood Biomarkers (2021) (31)
- Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection. (2011) (31)
- Soluble interleukin‐6 receptor strongly increases the production of acute‐phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes (1995) (30)
- IL-36 signaling in keratinocytes controls early IL-23 production in psoriasis-like dermatitis (2020) (30)
- Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET study (2018) (29)
- Type I IL-1 receptor mediates IL-1 and intracellular IL-1 receptor antagonist effects in skin inflammation. (2007) (29)
- The Activity of CCL18 is Principally Mediated through Interaction with Glycosaminoglycans (2013) (28)
- Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail (2020) (28)
- Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experience. (2013) (27)
- Severe Neutrophil-Dominated Inflammation and Enhanced Myelopoiesis in IL-33–Overexpressing CMV/IL33 Mice (2015) (27)
- Pre-interleukin-1alpha expression reduces cell growth and increases interleukin-6 production in SaOS-2 osteosarcoma cells: Differential inhibitory effect of interleukin-1 receptor antagonist (icIL-1Ra1). (2005) (27)
- Endogenous IL-1α is a chromatin-associated protein in mouse macrophages. (2013) (27)
- International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus. (2017) (27)
- Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis. (2006) (26)
- Granzyme A Contributes to Inflammatory Arthritis in Mice Through Stimulation of Osteoclastogenesis (2017) (26)
- The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries. (2020) (26)
- Etanercept in treatment of Felty’s syndrome (2005) (26)
- Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1 alpha precursor on cell motility. (2005) (26)
- Biological agents in monotherapy for the treatment of rheumatoid arthritis. (2014) (26)
- LB0003 Tocilizumab (TCZ) monotherapy is superior to adalimumab (ADA) monotherapy in reducing disease activity in patients with rheumatoid arthritis (RA): 24-week data from the phase 4 adacta trial (2012) (26)
- Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland (2020) (25)
- Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies. (2009) (25)
- Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance (2018) (24)
- Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor α agents: an open-label observational study (2006) (24)
- Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis. (2015) (24)
- Distinct Roles of Hepatocyte- and Myeloid Cell-Derived IL-1 Receptor Antagonist during Endotoxemia and Sterile Inflammation in Mice (2010) (24)
- The Effect of Comedication With a Conventional Synthetic Disease‐Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti–Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis (2016) (23)
- Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials (2017) (22)
- IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis (2000) (22)
- Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists (2012) (22)
- Circulating levels of IL‐11 and leukaemia inhibitory factor (LIF) do not significantly participate in the production of acute‐phase proteins by the liver (1996) (22)
- Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disease (2012) (21)
- The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis (2017) (21)
- The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes (2004) (21)
- IL‐1R1–MyD88 axis elicits papain‐induced lung inflammation (2016) (20)
- The role of the IL-1 system in pregnancy and the use of IL-1 system markers to identify women at risk for pregnancy complications† (2020) (19)
- Clinical evaluation of a cohort of patients with rheumatoid arthritis treated with anti-TNF-alpha in the community. (2006) (19)
- Intra-articular bioactivity of a p38 MAPK inhibitor and development of an extended-release system. (2015) (18)
- Atherosclerosis severity is not affected by a deficiency in IL‐33/ST2 signaling (2015) (18)
- Primary human articular chondrocytes, dedifferentiated chondrocytes, and synoviocytes exhibit differential responsiveness to interleukin‐4: Correlation with the expression pattern of the common receptor gamma chain (2002) (18)
- Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins (2010) (18)
- Adaptive Immune Response in JAM-C-Deficient Mice: Normal Initiation but Reduced IgG Memory1 (2009) (18)
- The advent of biosimilars: challenges and risks. (2014) (18)
- Long‐term therapy with anakinra in hidradenitis suppurativa in three patients (2019) (18)
- Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes (2020) (18)
- Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist. (2004) (17)
- AB0451 NI-0101, a Monoclonal Antibody Targeting Toll Like Receptor 4 (TLR4) Being Developed for Rheumatoid Arthritis (RA) Treatment with a Potential for Personalized Medicine (2015) (17)
- Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis (2017) (17)
- Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis. (2020) (17)
- Sulphasalazine-related life-threatening side effects: is N-acetylcysteine of therapeutic value? (1993) (17)
- IL-1 trap. Regeneron/Novartis. (2003) (16)
- Discrimination of C57BL/6J Rj and 129S2/SvPasCrl inbred mouse strains by use of simple sequence length polymorphisms. (2007) (16)
- Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice (2011) (16)
- Mice deficient in hepatocyte‐specific IL‐1Ra show delayed resolution of concanavalin A‐induced hepatitis (2012) (16)
- Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study. (2019) (16)
- Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries (2018) (16)
- Total hip prosthetic joint infection due to Veillonella species. (2004) (16)
- Immune-mediated experimental arthritis in IL-33 deficient mice. (2014) (15)
- Leukocyte migration to rheumatoid joints: Enzymes take over. (2006) (15)
- Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatments. (2012) (15)
- The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. (2017) (15)
- Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease (2008) (15)
- Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice (2003) (14)
- Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities (2020) (13)
- Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesions. (2011) (13)
- The Dermatologists' Role in Managing Psoriatic Arthritis: Results of a Swiss Delphi Exercise Intended to Improve Collaboration with Rheumatologists (2015) (13)
- Excess Serum Interleukin‐18 Distinguishes Patients With Pathogenic Mutations in PSTPIP1 (2021) (13)
- Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration (2017) (13)
- In Black Africans with rheumatoid arthritis, ACPA recognize citrullinated fibrinogen and the derived peptides α36-50Cit38,42 and β60-74Cit60,72,74, like in Caucasians. (2014) (13)
- Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis (2019) (12)
- CD 14 Is an Acute-Phase Protein 1 (2004) (12)
- Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory Responses (2017) (12)
- Balance between Interleukin-18 and Interleukin-18 binding protein in auto-inflammatory diseases (2022) (11)
- The human intracellular interleukin 1 receptor antagonist promoter appropriately regulates gene expression in keratinocytes and gastrointestinal epithelial cells in vivo. (1999) (11)
- Role of reproductive and menopausal factors in functional and structural progression of rheumatoid arthritis: results from the SCQM cohort (2018) (10)
- Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution. (2019) (10)
- The effect of comedication with a csDMARD on drug retention and clinical effectiveness of anti-TNF therapy in patients with axial spondyloarthritis (2018) (10)
- A systematic review of infliximab in the treatment of early rheumatoid arthritis (2007) (9)
- Adult seronegative arthritis with antinuclear antibodies: a distinct group of patients with a different immunogenetic pattern from seropositive rheumatoid arthritis and a good outcome. (1996) (9)
- Production of intracellular IL-1alpha, IL-1beta, and IL-1Ra isoforms by activated human dermal and synovial fibroblasts: phenotypic differences between human dermal and synovial fibroblasts. (2004) (9)
- Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA on the severity of rheumatoid arthritis. (2021) (9)
- Images in clinical medicine. Milwaukee shoulder. (2006) (9)
- Genetics: Mutations in the IL1RN locus lead to autoinflammation (2009) (9)
- Waldenström's Disease Complicated by Recurrent Meningococcal Arthritis (2001) (9)
- [Male-type scleroderma: the role of occupational exposure]. (1992) (8)
- Systemic effects of IL-6 blockade in rheumatoid arthritis beyond the joints. (2021) (8)
- [Efficacy of tumor necrosis factor-alpha blockade for severe sciatica?]. (2004) (8)
- Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α (2020) (8)
- Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis. (2011) (8)
- OP0030 RANDOMIZED CONTROLLED 24-WEEK TRIAL EVALUATING THE SAFETY AND EFFICACY OF BLINDED TAPERING VERSUS CONTINUATION OF LONG-TERM PREDNISONE (5 MG/D) IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO ACHIEVED LOW DISEASE ACTIVITY OR REMISSION ON TOCILIZUMAB (2019) (8)
- Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab (2017) (8)
- The Role of Interleukin 18/Interleukin 18-Binding Protein in Adult-Onset Still’s Disease and Systemic Juvenile Idiopathic Arthritis (2022) (8)
- The Effectiveness of Leflunomide as Co-Therapy of TNF inhibitors in Rheumatoid Arthritis . A Population Based Study (2009) (8)
- Efficacy of intra-articular bevacizumab for relapsing diffuse-type giant cell tumour (2014) (8)
- Production of IL-18 Binding Protein by Radiosensitive and Radioresistant Cells in CpG-Induced Macrophage Activation Syndrome (2020) (8)
- Is disk-related sciatica a TNFalpha-dependent inflammatory disease? (2005) (8)
- Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab (2019) (7)
- THU0174 Drug retention of tofacitinib versus biologic antirheumatic agents in rheumatoid arthritis: observational data from the swiss scqm registry (2017) (7)
- Adalimumab in severe and acute sciatica (2010) (7)
- Grobmyer, S. R. et al. Peptidomimetic fluoromethylketone rescues mice from lethal endotoxic shock: Paradoxical increase in products of caspase 1 (ICE). Mol. Med. 5, 585−594 (1999) (7)
- Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals. (2020) (7)
- 488 ADALIMUMAB IN SEVERE AND ACUTE SCIATICA. A MULTICENTRE, RANDOMISED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED TRIAL (2010) (6)
- Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling (2022) (6)
- Smoking and response to rituximab in rheumatoid arthritis: results from an international European collaboration (2018) (6)
- IL-36–Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid Cells (2016) (5)
- Efficacy of different doses of rituximab for the treatment of RA: data From the CERERRA collaboration (2012) (5)
- Lower level of synovial fluid interferon-c in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomatis reactive (2003) (5)
- Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease. (2020) (4)
- Relationship between gamma-interferon and interleukin-17 in Chlamydia trachomatis reactive arthritis. (2009) (4)
- The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis (2019) (4)
- SAT0206 Retention of tocilizumab as monotherapy versus tnf inhibitors with conventional synthetic dmards in rheumatoid arthritis patients with inadequate response to tnf inhibitors: a study from the tocerra collaboration (2017) (4)
- A systematic review of infl iximab in the treatment of early rheumatoid arthritis (2007) (4)
- Structural basis of human IL-18 sequestration by the decoy receptor IL-18 binding protein in inflammation and tumor immunity (2022) (4)
- Rheumatoid arthritis: from basic findings and clinical manifestations to future therapies (2017) (4)
- FRI0227 Sarilumab significantly suppresses circulating biomarkers of bone resorption and cardiovascular risk compared with adalimumab: biomarker analysis from the phase 3 monarch study (2017) (4)
- Non-infectious lupus pericarditis: a retrospective hospital-based observation in Yaoundé—Cameroon (2009) (4)
- Coexistence of seropositive rheumatoid arthritis and SAPHO syndrome. (2013) (4)
- Biological agents in the management of adult-onset Still's disease. (2019) (4)
- Oral Abstracts 7: RA ClinicalO37. Long-Term Outcomes of Early RA Patients Initiated with Adalimumab Plus Methotrexate Compared with Methotrexate Alone Following a Targeted Treatment Approach (2013) (3)
- Synovial Fluid Leptin Levels and Joint Pain in End-Stage Osteoarthritis: A Potential Explanation for Increased Pain in Women and in Obese Patients. (2011) (3)
- CS16-5. IL-36R Ligands are Potent Regulators of Dendritic and T Cells (2011) (3)
- Commentary Physiologic role of interleukin-1 receptor antagonist (2000) (3)
- The management of septic arthritis (2003) (3)
- FRI0169 Smoking and Response to Rituximab in Anti-CCP Positive and Negative Rheumatoid Arthritis – Results from an International European Collaboration (2015) (3)
- Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach (2022) (3)
- [The differential diagnosis of tenosynovitis]. (2011) (3)
- [Radiculopathy due to lumbar disc herniation]. (2009) (3)
- Presence of interleukin-17 in osteoarthritis: Does it indicate a different osteoarthritis phenotype (2015) (3)
- [Best practice use of corticosteroids in rheumatoid arthritis]. (2014) (2)
- P024 Comparison of CCP2 and CCP3 assays in a large cohort of established rheumatoid arthritis and controls (2018) (2)
- IL-33: a novel cytokine with proinflammatory properties (2007) (2)
- Tocilizumab versus adalimumab for rheumatoid arthritis – Authors’ reply (2013) (2)
- Mice deficient in leptin (ob/ob) or in liptin receptor (db/db) have a milder form of antigen-induced arthritis (2001) (2)
- THU0130 Distinct Biomarkers Enrich for Clinical Response to Tocilizumab (TCZ) and Adalimumab (ADA) in Adacta: A Head-to-Head Monotherapy Study in Patients (PTS) with Methotrexate (MTX)-IR Rheumatoid Arthritis (RA) (2013) (2)
- SAT0687 EVOLVING THE MANAGEMENT OF RHEUMATOID ARTHRITIS THROUGH DEVELOPMENT OF PRACTICAL AND EDUCATIONAL TOOLS (2019) (2)
- Agreement of Mexican rheumatologists with the ASsessment in Ankylosing Spondylitis International Working Group and the EUropean League Against Rheumatism recommendations for the management of ankylosing (2006) (2)
- Review The role of leptin in innate and adaptive immune responses (2006) (2)
- OR6-004 – MRP8/14 promote MSU-crystal induced inflammation (2013) (2)
- Randomized clinical trials in ANCA-associated vasculitis: a systematic analysis of the WHO - International Clinical Trials Registry Platform (2020) (2)
- FRI0328 Fixed versus On-Flare Retreatment with Rituximab in RA – Results from the Cererra Collaboration (2014) (2)
- SAT0677 Prevotella copri in individuals at risk for rheumatoid arthritis (2018) (2)
- OP0099 Toll-like receptor 4 agonists MRP 8 and MRP 14 act as endogenous enhancers of MSU-crystal induced IL-1 secretion in vitro and reflect disease activity in gout patients in vivo (2013) (2)
- THU0086 Seropositivity and response to RTX: Data from the cererra collaboration (2013) (2)
- FRI0450 Commonalities and differences in data collection across european spondyloarthritis registries (2017) (2)
- THU0131 Levels of cxcl13 and sicam1 correlate with disease activity score in rheumatoid arthritis (RA) patients treated with tocilizumab (TCZ) (2018) (1)
- Intra-Articular Drug Delivery Systems for Osteoarthritis Treatment (2010) (1)
- FRI0582 Open-label, multicenter, dose-escalating phase ii clinical trial on the safety and efficacy of tadekinig alpha in adult onset still's disease (2017) (1)
- SAT0036 Retention of Tocilizumab Therapy: A Comparison between Tocilizumab in Monotherapy and in Combination with DMARDS Based on the Tocerra Collaboration (2014) (1)
- Disease-modifying antirheumatic drugs (2014) (1)
- THU0075 EARLY VERSUS DELAYED START OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A PHASE 3 TRIAL OF PATIENTS NAÏVE TO METHOTREXATE TREATMENT (2019) (1)
- In vitro activity of P38 MAPK inhibitor-loaded particles for the long term intra-articular treatment of osteoarthritis (2011) (1)
- 02.11 Il-38 is not involved in the modulation of imq-induced skin inflammation (2017) (1)
- Structural basis of human IL-18 sequestration by the decoy receptor IL-18 binding protein (IL-18BP) in inflammation and tumor immunity (2022) (1)
- Syndrome de Behçet (2008) (1)
- IL-36: An Epithelial Cytokine Important in Psoriasis (2014) (1)
- 60: Atherosclerosis severity is independent of endogenous IL-33 signaling (2014) (1)
- Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools. (2020) (1)
- FRI0071 Predictors for The Development of anti-Citrullinated Protein Antibodies in Individuals Genetically at Risk for Rheumatoid Arthritis (2016) (1)
- A7.13 Distinct expression of IL-36α, β, γ and their antagonists IL-36RA and IL-38 in psoriasis, rheumatoid arthritis (RA) and crohn’s disease (CD) (2016) (1)
- [Redefining treatment of rheumatic arthritis with anti-cytokines]. (2007) (1)
- Travel patterns, risk behaviour and health problems of travellers with rheumatic diseases compared to controls: A multi-centre, observational study. (2020) (1)
- FRI0221 Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-tnf mode of action? (2017) (1)
- Adipokines correlate with pain and function in lower limb osteoarthritis: different associations in hip and knee (2014) (1)
- NLRP3 Q703K and TNFRSF1A R92Q mutations in a patient with auto inflammatory disease (2015) (1)
- THU0177 Structural Differences Between Anti-TNF Agents are Associated with Dissimilar Rates of Secondary Loss of Effectiveness and Drug Adjustments (2013) (1)
- AB0178 Menopause Is A Predictor for The Development of Anti-Citrullinated Protein Antibodies in Women at Risk for Rheumatoid Arthritis (2016) (1)
- THU0245 Post-Vaccinal Arthritis in an Ebola Vaccine Trial with a Live-Attenuated Recombinant Virus Expressing the Ebola Surface Glycoprotein (RVSV-ZEBOV) (2015) (1)
- OP0166 Antibodies Against Periodontal Pathogens are not Associated with Joint Swelling or Autoimmunity Associated with RA in a Cohort of Healthy Individuals at Increased Risk of Rheumatoid Arthritis (2015) (1)
- P093/O16 IL-36 signaling in keratinocytes is mandatory in imiquimod-induced psoriasis in mice (2019) (1)
- Statins have no effect on collagen-induced arthritis in mice (2004) (1)
- [Review of the protective effects of tumor necrosis factor inhibitors in rheumatoid arthritis]. (2004) (1)
- AB1368-HPR ENHANCED ROLE OF NURSES AND OTHER HEALTHCARE PROFESSIONALS (HCPS) IN THE CARE OF RHEUMATOID ARTHRITIS AND ASSOCIATED COMORBIDITIES (2019) (1)
- Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis? (2008) (1)
- Reply to Xie et al. about the article "Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis". (2013) (1)
- Consensus guidelines on the cardiovascular risk management in patients with rheumatoid arthritis (2015) (1)
- SAT0588 COMPARATIVE EFFECTIVENESS RESEARCH IN OBSERVATIONAL SETTINGS: EVALUATING TWO NEW METHODS TO ANALYSE RESPONSE RATES (2019) (1)
- Response to: ‘When binary and continuous responses disagree’ by Dr Ouyang (2019) (1)
- [Adverse events of biologic therapies]. (2017) (1)
- Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration (2016) (1)
- Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update (2022) (1)
- Synovial Fluid Leptin Level Is Associated with Residual Pain and Functional Disability One Year After Total Joint Arthroplasty (2012) (1)
- Inflammation and autoimmune responses are independent of peripheral MHC class II expression driven by CIITA pIV in collagen induced arthritis (2011) (0)
- PARE0018 ENABLING PATIENT-CENTRED CARE IN RHEUMATOID ARTHRITIS AND ASSOCIATED COMORBIDITIES (2019) (0)
- FRI0099 Obese patients with rheumatoid arthritis have reduced response rates to biologic anti-rheumatic agents: a comparison between european and american ra patients (2013) (0)
- Stingelin and Cem Gabay (2004) (0)
- SAT0083 Tooth loss is associated with swollen joints in a cohort of healthy individuals at increased risk of developing rheumatoid arthritis (2013) (0)
- This information is current as Inflammation in Mice during Endotoxemia and Sterile Cell-Derived IL-1 Receptor Antagonist Distinct Roles of Hepatocyte-and Myeloid (2010) (0)
- SAT0005 DETECTION OF HIGHLY EXPANDED T CELL CLONES IN THE PERIPHERAL BLOOD OF AT RISK INDIVIDUALS FOR RHEUMATOID ARTHRITIS BEFORE THE CLINICAL ONSET OF THE DISEASE (2019) (0)
- [Rheumatological arthroscopy]. (2005) (0)
- Genomic / genetic / proteomic : the added value to arthritis research and treatment 1 Osteoarthritis : degeneration of matrix or cells ? (2015) (0)
- Inadequate reporting of concomitant medications in rheumatology randomized controlled trials of pharmacologic interventions. (2019) (0)
- FRI0070 Ultrasound doppler activity correlates with systemic autoimmunity and swollen joints in a healthy population at risk for rheumatoid arthritis (2013) (0)
- Interleukin-33 expression in human arthritis (2011) (0)
- Interleukin 33 expression in human arthritis (2011) (0)
- Cross-talk between IL-6 trans-signaling and AIM2 inflammasome/IL-1β axes bridge innate immunity and epithelial apoptosis to promote emphysema (2022) (0)
- Novel intracellular function of IL-1 receptor antagonist type 1 in endothelial cells (2003) (0)
- PRECISION MEDICINE: MAXIMISING TREATMENT BENEFIT FOR RHEUMATOID ARTHRITIS PATIENTS (2016) (0)
- Neuropathic Pain After Primary Total Hip and Knee Arthroplasty (2013) (0)
- 117 Interleukin-33 Induces the Production of Pro-inflammatory Cytokines by Mast Cells (2007) (0)
- Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies (2020) (0)
- [Connective tissue diseases, a matter for specialists?]. (2013) (0)
- O025 Unopposed interleukin 18 signalling leads to severe toll like receptor 9-induced macrophage activation syndrome in mice (2018) (0)
- A2.32 Macroautophagy proteins control dendritic cell activation and shape the TH1/TH17 response during antigen induced arthritis (2016) (0)
- Treatment with anti-JAM-C antibody decreases the severity of antigen-induced arthritis (2011) (0)
- FRI0088 Comparison of Rheumatoid Factor, Anti-Citrullinated Protein Antibodies, Anti-Carbamylated Protein Antibody, Anti-Peptidyl Arginine Deiminase Type-3 Antibodies and Calprotectin in Patients with Rheumatoid Arthritis and Spondyloarthritis (2016) (0)
- THU0135 Shorter Drug Retention in Rheumatoid Arthritis Patients Treated with Biological Dmards in Monotherapy – an Observational Cohort Analysis (2013) (0)
- AB1382 Reasons for hospitalization of patients with rheumatologic disorders (2013) (0)
- O034 Expression of the decoy type 2 interleukin-1 receptor in mouse and its putative role in inflammation (2012) (0)
- Mice db / db Response in on Lymphocyte Populations and Immune Indirect Effects of Leptin Receptor Deficiency and Cem (2006) (0)
- Comparison of energy expenditure between patients with rheumatoid arthritis and healthy controls (0)
- Author's reply (1994) (0)
- Work and rehabilitation PARE0016 IMPACT OF AXIAL SPONDYLOARTHRITIS ON PATIENTS’ PROFESSIONAL LIFE: RESULTS FROM THE ONLINE SURVEY EMAS OF 638 FRENCH PATIENTS (2021) (0)
- P157 Radioresistant and radiosensitive cells contribute to IL-18BP production in a model of macrophage activation syndrome (2019) (0)
- [Low back pain, frequent symptoms with multiple facets]. (2009) (0)
- , Ursula Lipoprotein Chlamydia trachomatis Potentiator , a Localization of Macrophage Infectivity Molecular Characterization and Subcellular (2007) (0)
- OP0165 Changes in Lipoprotein(A) after Treatment with Tocilizumab (TCZ), Adalimumab (ADA), and Methotrexate (MTX) in Patients with Rheumatoid Arthritis (RA) (2014) (0)
- [The state of rheumatoid arthritis, 2014]. (2014) (0)
- O035 IL-33 and ST2 KO mice display different phenotypes in K/BxN serum transfer-induced arthritis (2012) (0)
- AB0251 Female Reproductive Factors and the Development of Anti-Citrullinated Protein Antibodies in Women at Risk of Rheumatoid Arthritis (2015) (0)
- Targeting interleukin-1 in rheumatic diseases (2007) (0)
- Arthritis in Mice but Has No Impact on Aggravates K / BxN Serum Transfer-Induced Deficiency in IL-1 Receptor Type 2 (2017) (0)
- Attenuates Experimental Arthritis and Cellular Immune Responses and Leptin Signaling Deficiency Impairs Humoral (2001) (0)
- Interleukin-1 and its receptor antagonist in inflammatory arthritis (2015) (0)
- AB0274 THE PREDICTIVE VALUE OF RHEUMATOID FACTOR, ANTI-CITRULLINATED PROTEIN ANTIBODIES, ANTI-CARBAMYLATED PROTEIN: ANTIBODIES AND ANTI-PEPTIDYL ARGININE DEIMINASE TYPE-3 ANTIBODIES, ALONE OR IN COMBINATION, ON RADIOGRAPHIC DAMAGE IN RHEUMATOID ARTHRITIS (2019) (0)
- THU0238 Risk Factors for the Development of Anti-Citrullinated Protein Antibodies in Individuals Genetically at Risk for RA (2014) (0)
- Concise report Absence of up-regulation for a proliferation-inducing ligand in Sjo¨gren’s sialadenitis lesions RHEUMATOLOGY (2011) (0)
- Synovial tissues concentrate secreted APRIL GABAY , Cem (2019) (0)
- Oligopeptide antagonist of IL-6: a novel approach to target IL-6 activities (2007) (0)
- Reporting of and representativeness of race, ethnicity and socioeconomic status in systemic sclerosis randomized trials: an observational study. (2022) (0)
- [Rheumatoid arthritis, methothrexate, and pulmonary fibrosis: which evidences?]. (2010) (0)
- SAT0692 Breastfeeding is not associated with anti-citrullinated antibodies development in individuals at risk for rheumatoid arthritis (2018) (0)
- Rheumatoid arthritis: from basic findings and clinical manifestations to future therapies (2017) (0)
- Targeted IL-1 inhibition (2004) (0)
- Cardiovascular risk in patients with rheumatoid arthritis (2017) (0)
- Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines Cytokine (2016) (0)
- [Ultrasound: an indispensable tool for the rheumatologist]. (2011) (0)
- IL-18 Binding Protein-Producing Cells Attenuate Anemia in Murine Macrophage Activation Syndrome. (2023) (0)
- Molecular characterization and subcellular localization of macrophage 1 infectivity potentiator , a Chlamydia trachomatis lipoprotein 2 3 (2007) (0)
- 02.12 Il-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro (2017) (0)
- [Osteoarthrosis--where are we going in 2012]. (2012) (0)
- Palindromic syndrome: appearance of chondrocalcinosis after 47 years of evolution. (1993) (0)
- Patients With Xiap Deficiency Have Circulating Free Il-18 Which May Represent A Therapeutic Target (2017) (0)
- Antibodies against periodontal pathogens are not associated with joint swelling or autoimmunity associated with RA in a cohort of healthy individuals at increased risk of rheumatoid arthritis (2015) (0)
- [Spondylarthropathies in 2015]. (2016) (0)
- SAT0103 Risk of Major Adverse Cardiovascular Events in A Swiss Cohort of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondylarthritis (2016) (0)
- Gene therapy: will it deliver for RA? (2001) (0)
- [Inflammatory arthritides pathotypes]. (2019) (0)
- THU0638 CONSIDERATIONS FOR IMPROVING QUALITY OF CARE IN RHEUMATOID ARTHRITIS AND ASSOCIATED COMORBIDITIES (2019) (0)
- Drugs ? Remission . Do Biologics Perform Better Than Synthetic Antirheumatic Joint Damage Progression in Patients with Rheumatoid Arthritis in Clinical (0)
- PS2-035. The mouse interleukin (IL)-33 gene is expressed in cell and stimulus dependent manner from two alternative promoters (2011) (0)
- FRI0187 Rituximab Done! What's Next in Rheumatoid Arthritis? A European Observational Longitudinal Study Assessing the Effectiveness of Biologics After Rituximab Treatment in Rheumatoid Arthritis (2015) (0)
- AB0698 Overlaping Spondylarthritis and Periodic Autoinflammatory Syndrome? A “Bed to Bench” Story (2014) (0)
- CS12-5. Which chemokine receptor should we target in Rheumatoid Arthritis (2011) (0)
- OP0028 Efficacy of different doses of rituximab for the treatment of RA: Data from the cererra collaboration (2013) (0)
- Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls. (2022) (0)
- THU0088 Iron Deficiency and Low Erythropoietin Concentrations Are Frequent Anemia Causing Factors in Rheumatoid Arthritis (2016) (0)
- Production and biological role of hepatocyte and myeloid cell-derived interleukin-1 receptor antagonist in a model of systemic inflammation (2010) (0)
- 61 – Cytokine neutralizers: Interleukin-1 inhibitors (2015) (0)
- OP0060 Mice deficient in leptin (ob/ob) or in leptin receptor (db/db) have a milder form of antigen-induced arthritis (2001) (0)
- FRI0123 Comparative effectiveness of subcutaneous versus intravenous tocilizumab in a pan-european collaboration of registries (2018) (0)
- A role for leptin in immune-mediated inflammatory diseases? (2004) (0)
- P097 Intracellular interleukin-1 receptor antagonist released upon cell death acts as an alarmin inhibitor in aldara cream-induced psoriasis-like skin inflammation (2019) (0)
- P181 IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naïve CD4+ T cells (2012) (0)
- SAT0104 Comparison of Drug Discontinuation to Inefficacy and Adverse Events Between Anti-Tnf Agents and ‘Non-Anti-Tnf Biologic Agents’ in Anti-Tnf Inadequate Responder Rheumatoid Arthritis Patients (2013) (0)
- mediators of host defense : identification of early Pseudomonas aeruginosa Transcriptional response of bronchial epithelial cells to (2015) (0)
- Osteoarthritis Therapy: Nanocrystal–Polymer Particles: Extended Delivery Carriers for Osteoarthritis Treatment (Small 8/2018) (2018) (0)
- Special Issue "IL-1 family cytokines in host defense, inflammation and cancer". (2022) (0)
- Leptin may influence RA in opposing ways : enhance the expression of Th 1 cytokines or limit the inflammatory responses (2003) (0)
- AB0262 SERUM CALPROTECTIN AS A MARKER OF DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS (2019) (0)
- The Relationship Between Efficacy and Toxicity in Patients with Rheumatoid Arthritis Receiving Methotrexate in Combination with Adalimumab (2015) (0)
- [Soft tissue rheumatic disorders: important for general practice]. (2015) (0)
- OP0182 The Impact of Statin Use on Structural Bone Damage in Rheumatoid Arthritis (2015) (0)
- [The management of osteoarticular problems by internal/general practitioners is inadequate. Is this a problem?]. (2005) (0)
- SP0002 Therapy of Rheumatoid Arthritis (2013) (0)
- A10.02 Deficiency in IL-1 receptor type 2 aggravates K/BXN serum transfer-induced arthritis in mice, but has no effect in endotoxemia (2016) (0)
- OP0093 Il-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro (2017) (0)
- Secreted IL-1Ra exerts a protective effect on atherosclerotic lesion development in apolipoprotein-E-deficient mice (2003) (0)
- A systematic review of in fl iximab in the treatment of early rheumatoid arthritis (2007) (0)
- 68 Biological role of myeloid cell-derived interleukin-1 receptor antagonist in collagen-induced arthritis (2008) (0)
- ID: 147: IL-1 cytokines – The balance between agonists and antagonists in health and disease (2015) (0)
- FRI0701 Does parity influence joint damage progression in women with rheumatoid arthritis? (2017) (0)
- IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4 (cid:1) T cells (2012) (0)
- Production of interleukin (IL)-1 receptor antagonist by human articular chondrocytes (2002) (0)
- AB0004 Characterization of Putative Pre-RA Signatures by Transcriptome Analysis (2015) (0)
- ID: 129: Role of the IL-36 pathway in inflammatory responses in mouse neonates (2015) (0)
- A5.19 In African Patients with Rheumatoid Arthritis ACPA Recognise Citrullinated Fibrinogen and the Immunodominant Epitopes Borne by the Fibrin Peptides α36–50 and β60–74, Like in Caucasians (2013) (0)
- THU0110 The importance of sustained remission for longterm outcomes in patients with rheumatoid arthritis (2017) (0)
- SAT0229 Effectiveness of Repeated Courses of Rituximab in RA – Results from the Cererra Collaboration (2014) (0)
- 67 Biological role of hepatocyte-derived interleukin-1 receptor antagonist in a model of systemic inflammation (2008) (0)
- A5.12 Atherosclerosis severity is independent of endogenous IL-33 signalling (2015) (0)
- Arthritis and Rheumatism (2006) (0)
- SAT0318 Association between joint pain severity and serum leptin levels in hand osteoarthritis (2013) (0)
- SP0142 Interleukin-36: A key cytokine for innate and adaptive immune responses (2013) (0)
- Contributors (2012) (0)
- Predictors of infection in patients treated with rituximab for autoimmune diseases (0)
- Effectiveness Of Tocilizumab In Monotherapy and In Combination With Different Synthetic Dmards: A Registry-Based Comparison Study (2013) (0)
- ID: 133: IL-36 acts on myeloid cells and exerts stronger stimulatory effects compared to IL-1 in M2-polarized macrophages (2015) (0)
- The cytosolic DNA sensor AIM2 promotes Helicobacter‐induced gastric pathology via the inflammasome (2023) (0)
- A1.23 Macroautophagy deficiency in dendritic cells exacerbates antigen-induced arthritis (2015) (0)
- [Rheumatology in the aged]. (2010) (0)
- Authors' replies (1995) (0)
- ID: 138: Deficiency in IL-1 receptor type 2 aggravates K/BxN serum transfer-induced arthritis in mice, but has no effect in endotoxemia (2015) (0)
- [Rheumatic diseases and infections]. (2006) (0)
- THU0202 Comparative effectiveness of tocilizumab as monotherapy versus tnf inhibitors in combination with conventional synthetic disease modifying antirheumatic drugs in bio-naÏve patients with rheumatoid arthritis (2018) (0)
- 35 – Biologic Agents (2012) (0)
- Intracellular IL-1 receptor antagonist (icIL-1Ra1) does not antagonize growth inhibitory effects of pre-IL-1α in SaOS-2 cells (2005) (0)
- Interleukin-1 Receptor Antagonist Isoforms in Collagen-Induced Arthritis (1999) (0)
- Effects of leflunomide on interleukin-1 receptor antagonist (IL-1Ra) synthesis in chondrocytes and synovial fibroblasts (2003) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Cem Gabay?
Cem Gabay is affiliated with the following schools: